Forecast: Import of Glands and Other Organs for Organo-Therapeutic Uses to France

The forecast for France's import of glands and other organs for organo-therapeutic uses is set to gradually rise from $1.0136 billion in 2024 to $1.0427 billion in 2028. This consistent upward trend suggests an increase in demand and market expansion over the five-year period, averaging a year-on-year growth rate of approximately 0.7% annually.

In 2023, the import value stood slightly lower, indicating a growing acceptance and reliance on these therapeutic products. The estimated Compound Annual Growth Rate (CAGR) for the 2024-2028 period underscores steady growth.

Future trends to watch include potential impacts from advancements in biotechnology, regulatory changes, and shifting health priorities that could further accelerate or decelerate this import growth trajectory.